Compare Novo Nordisk A/S (NVO) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Taskus Inc — how do they compare? Novo Nordisk A/S trades at $49.37 (market cap $220.53B), while Taskus Inc trades at $5.86 (market cap $532.07M). The key difference: Novo Nordisk A/S is far larger — about 414.5× Taskus Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Taskus Inc pays none. Which is the better fit depends on your goals.
| NVO | TASK | |
|---|---|---|
Market Cap | $220.53B | $532.07M |
Sector | Health | Technology |
52-Week High | $71.70 | $18.21 |
52-Week Low | $35.29 | $4.57 |
Enterprise Value | $239.49B | $927.77M |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
